Quality assurance in humanitarian medical supply chains

Published on January 2017 | Categories: Documents | Downloads: 26 | Comments: 0 | Views: 495
of 33
Download PDF   Embed   Report

Comments

Content

Quality assurance in humanitarian medical supply chains

June 2013

Dennis Bours, [email protected] Independent Assessment Report Certification in Humanitarian Medical Logistics Practices, Fritz Institute
Please consider the environment before printing

[This page has been left blank intentionally for double-sided printing]

Page 2 of 33

Executive summary
The primary objective of humanitarian assistance is to save lives, alleviate suffering, and maintain and restore human dignity. The focus of this publication is on humanitarian medical assistance, and more specifically on quality assurance in humanitarian medical supply chains. Humanitarian medical supply chains should be developed for flexibility reflected their ability to cope with changing levels of responsiveness and the speed of scaling up or down. Medical humanitarian assistance and related supply chain structure should take into account response phases and related supply chain types an intervention might need to shift to and progress through over time.

Changing intervention phases, supply chain responsiveness required, levels of uncertainty in operational context as well as beneficiary demand and inadequate structural funds for the humanitarian supply chain function will impact and limit both the ability and speed of switching supply chain types and related quality assurance measures for and management of the medical supply chain. Humanitarian organizations implementing medical programs in a variety of response phases often follow the essential medicines lists of the WHO, the recipient country’s MoH essential medicine list if more stringent, or internationally agreed upon and WHO-inspired catalogues of standardized medical items. Operating in the emergency response phase, humanitarian organizations often make use of the IFRC or interagency emergency health kits, which have been pre-qualified and cover the minimum needs for a basic health-care system under emergency circumstances. WHO/UN essential medicine lists, related pre-qualified suppliers and interagency emergency health kits meet the medicine quality aspects as discussed in Chapter 2 and follow stringent quality assurance rules as discussed in Chapter 3, which make them the preferred procurement choice.
Page 3 of 33

Quality assurance throughout the supply chain is complex due to large number of stakeholders involved and the fact that big parts of the supply chain, both downstream as well as upstream, will be external to the humanitarian organization implementing or taking part in a medical intervention. Despite these complexities some recommendations towards quality assurance are given for the supply chain management process in general and for each main supply chain component, i.e. procurement and order management, transport, and warehousing and inventories, in Chapter 4. The most obvious of recommendations concentrate on the need for clearly formulated roles and responsibilities, policies and procedures, and clear information flows, suitable for the particular programme, both in general technical terms as well as towards quality assurance. Procurement should be limited to pre-qualified suppliers from “stringently regulated” countries and/or medical Humanitarian Procurement Centres (HPCs), taking into account the reverse flow of goods, and all items should have not only technical specifications, but also quality indicators/specifications. Transport must take place in line with international and national regulations and specific handling requirements of items transported. When focusing on warehousing; rules, roles and regulations for the inspection, quality control and handling should be the same for all warehousing environments, irrespective of the actor managing it and clear minimum standards should be put in place.

Moving through the different response phases, quality assurance will need to be balanced against needed responsiveness and anticipated uncertainty of demand / operational context, coming at a certain financial cost. The responsive phases – emergency and transitional phases – will focus on a coordinated response, emergency health kits, pre-positioned stocks and air transport, while in the more efficient supply chain phases – developmental and risk reduction phases – will focus on open tendering, development of blanket purchasing agreements, capacity development and more efficient mixed transport modes. Quality assurance in humanitarian medical supply chains demands a coordinated multi-stakeholder approach, which could be improved by integrating current medical Humanitarian Procurement Centres (HPCs) into the International Health Partnership (IHP+) to guarantee their adherence to all medical good practice standards, a higher level of coordination between HPCs and provision of services by all stakeholders under IHP+ that go beyond their internal medical supply chain and current level of service, ie. supply of trainers, quality assessors, emergency pharmacists, etc. Another solution might be to only accept humanitarian actors in humanitarian medical interventions who can guarantee a minimum level of quality assurance in their work processes and outputs. This would also make sense to curtail the uncontrollable flood of humanitarian initiatives after a disaster.
Page 4 of 33

Table of Contents
Executive summary ................................................................................................................................. 3 List of abbreviations ................................................................................................................................ 6 List of figures ........................................................................................................................................... 7 List of tables ............................................................................................................................................ 7

1. Introduction......................................................................................................................................... 9 2. Aspects of medicine quality .............................................................................................................. 11 2.1 Common denominators of medicine quality .............................................................................. 11 2.2 Essential medicines ..................................................................................................................... 13 3. Critical elements of medical quality assurance ................................................................................. 15 3.1 Quality assessment vs. quality assurance ................................................................................... 16 3.2 Certification and quality assurance ............................................................................................. 16 4. Quality assurance throughout the supply chain ............................................................................... 18 5. Humanitarian response phases and quality assurance ..................................................................... 20 6. Concluding ......................................................................................................................................... 21

References ............................................................................................................................................. 23 Recommended reading ......................................................................................................................... 29

Page 5 of 33

List of abbreviations
3PL BAN BOND BP DG ECHO EC EDQM-PQS EMEA GDP GMP GSP GTDP HPC IATA IFRC IHP+ INN ISO MDGs MoH MSF MSH PAHO QA RCRC SCM SHO Third-party logistics British approved name British Overseas NGOs for Development British Pharmacopoeia standards European Commission’s Directorate General for Humanitarian Aid European Commission European Pharmacopoeia Reference Standards European Medicines Agency Good distribution practices Good manufacturing practices Good storage practices Good trade and distribution practices Humanitarian Procurement Centre International Air Transport Association International Federation of Red Cross and Red Crescent Societies International Health Partnership International non-proprietary name International Standards Organization Millennium Development Goals Ministry of Health Médècins Sans Frontières Management Sciences for Health Pan-American Health Organization Quality assurance Red Cross and Red Crescent movement Supply chain management Stichting Samenwerkende Hulporganisaties,
Page 6 of 33

Dutch: Cooperating Aid Organizations UN UNICEF UNOPS USAID USAN USP WHO United Nations United Nations Children’s Fund United Nations Office for Project Services United States Agency for International Development United States adopted name United States Pharmacopeia Convention World Health Organization

List of figures
Figure 1: Humanitarian response phases and corresponding supply chain types ................................ 10 Figure 2: Elements of a quality assurance system ................................................................................ 15 Figure 3: Humanitarian response phases and medical procurement actions....................................... 20

List of tables
Table 1: Substances with potential bioavailability problems ................................................................ 12 Table 2: Substances with stability issues............................................................................................... 12 Table 3: WHO criteria for the selection of essential medicines ............................................................ 13

Page 7 of 33

[This page has been left blank intentionally for double-sided printing]

Page 8 of 33

1. Introduction
The primary objective of humanitarian assistance is to save lives, alleviate suffering, and maintain and restore human dignity, without regard for race, ethnicity, religion or political affiliation. Humanitarian action should be undertaken for the benefit of vulnerable people, guided by principles of humanity, impartiality, neutrality and independence. It should facilitate the return to normal lives, seeking to lessen the destructive impact of disasters and complex emergencies.1 The focus of this publication will be on humanitarian medical assistance, more specifically on quality assurance in humanitarian medical supply chains. Certain literature focusing on humanitarian medical standards is written specifically towards medical assistance in (post-)disaster settings, e.g. the PAHO Guidelines on humanitarian medical supply chain management (SCM), the EC guidelines for quality assurance (QA) in medical humanitarian aid and the Sphere minimum standards in health action.2 Other guidelines focus on medical SCM in humanitarian assistance, not specifying the humanitarian intervention phase, e.g. the USAID Deliver project guidelines and MSH guideline on managing access to essential medicines and health technology.3 Irrespective of the approach, humanitarian medical supply chains should be developed for flexibility reflected in being able to cope with changing levels of responsiveness and speed of scaling up or scaling down. Medical humanitarian assistance and related supply chain structure should take into account response phases and related supply chain types an intervention might need to shift to and progresses through over time, visualized in Figure 1. Within each phase the humanitarian actor strives to work in or close to the zone of strategic fit, hence finding the optimum situation to balance beneficiary needs against supply chain capability and balance programmatic and supply chain strategies to one another to guarantee (cost) efficiency.4 It should be understood that the supply chain function in humanitarian assistance is a support function towards core (medical) activities and often receives its funding as a percentage of donor funding or pledges for the implementation of core activities. The lack of structural support, understanding of its value added and lack of acknowledgement of its importance has resulted in limited longer term coordination and vision in humanitarian supply chain practices.5

1 2 3 4 5

IFRC 2002; SPHERE 2011. PAHO 2001; Pomatto and Schuftan 2006; SPHERE 2011, pp. 287-354. Owens and Warner 2003; USAID 2011; MSH 2012. Cohen and Roussel 2005; Sunil and Meindl 2009; Chopra and Meindl 2013. Buchanan-Smith and Randel 2002; Gustavsson 2003; Van Wassenhove 2006; Lee and Lee 2007.

Page 9 of 33

Figure 1: Humanitarian response phases and corresponding supply chain types Changing intervention phases, supply chain responsiveness required, levels of uncertainty in beneficiary demand as well as operational context and inadequate structural funds for the humanitarian supply chain function will impact and limit both the ability and speed of switching supply chain types and related quality assurance measures needed.

Chapter 2 focuses on aspects of medicine quality, related quality indicators and the concept of essential medicines. Quality assurance (QA) and its critical elements are discussed in Chapter 3, with a focus on quality assessment vs. assurance and the role of certification. In Chapter 4 recommendations towards quality assurance are given for the supply chain management process in general and for each main supply chain component, i.e. procurement and order management, transport, and warehousing and inventories. Going back to the humanitarian response phases, Chapter 5 looks at key medical procurement and supply chain management actions exemplified in each response phase. This report concludes in Chapter 6 with some observations towards the future of coordination and quality assurance in humanitarian medical supply chains.

Page 10 of 33

2. Aspects of medicine quality
An in-depth literature review6 showed that pharmaceutical quality can be qualified and tested in many ways. The European Pharmacopoeia Reference Standards (EDQM-PQS), the British Pharmacopoeia standards (BP) and the United States Pharmacopeia Convention (USP) are three standards used frequently in developing settings, with each their specific strengths and limitations.7

2.1 Common denominators of medicine quality
Despite the absence of one uniform definition of pharmaceutical quality, and small differences in the various existing standards, common denominators can be identified and these are presented below: Identity: The correct active ingredient is present, certified by laboratory testing, and specified by the international non-proprietary name of the active ingredient (INN) or the British approved name (BAN) or United States adopted name (USAN)8. Pharmacopoeial standard: A medicine is of good quality if its characteristics meet the standards described in a widely accepted pharmacopoeia such as the European Pharmacopoeia Reference Standards (EDQM-PQS), the British Pharmacopoeia standards (BP) or the United States Pharmacopeia Convention (USP). Purity: The medicine is not contaminated with potentially harmful substances. Potency: The correct amount of active ingredient is present and certified by laboratory testing, usually between 95 and 110 percent of the labelled amount. Uniformity: Consistency of, shape, and size of the dosage form do not vary. Bioavailability: Bioavailability refers to the speed and completeness with which an administered medicine enters the blood stream, which must be consistent to provide a predictable therapeutic result. Medicine bioavailability differences exist between manufacturers of the same product. A number of oral medicines have known bioavailability issues (Table 1)9. Careful evaluation of generic

6

EC 1994; WHO 1997; PAHO 2001; EC 2003; WHO 2003A and 2003B; Toutain and Bousquet-Melou 2004; WHO 2005; Pomatto and Schuftan 2006; WHO 2007; MSH 2007, pp.108-122; WHO 2009; EC 2010; MSF 2010; WHO 2010A, 2010B and 2010C; IFRC 2011A and 2011B; PATH 2011; UNICEF 2011; USAID 2011; WHO 2011A, 2011B, 2011C, 2011D and 2011E; Dasaklis, Pappis and Rachaniotis 2012; MSH 2012; WHO 2012; EC 2013; Mosadeghrad 2013.

7 8

MSH 2012, pp. 351-370. INN in line with the European Pharmacopoeia Reference Standards (EDQM-PQS), BAN in line with the British Pharmacopoeia standards (BP) or USAN in line with the United States Pharmacopeia Convention (USP).

9

EMEA 2000; EMEA 2010; MSH 2012.

Page 11 of 33

medicines may be necessary, but if purchasing is done through established and reliable suppliers, the bioavailability of most brand-name and generic medicines used in primary health care is sufficient.

Table 1: Substances with potential bioavailability problems Stability: The activity of the medicine is ensured for the period of time stated on the product label, that is, until the expiration date. Improper storage and distribution can lead to physical deterioration and chemical decomposition, reduced potency, and occasionally, formation of toxic by-products of degradation. Some medicines have found to be more sensitive to tropical conditions and excessive temperatures (over 40 ⁰C). An overview of medicines with stability problems is presented in Table 2.

Table 2: Substances with stability issues Shelf life: The medicine has a shelf life of 2 years, that is, up to expiration date, or for products with a shelf life of less than two years at time of manufacture, at least 75% of the life must be remaining.

Page 12 of 33

2.2 Essential medicines
Up to 70 percent of all pharmaceuticals are duplicative or non-essential.10 The World Health Organization (WHO) defines essential medicines as “those that satisfy the priority health care needs of the population. They are selected with due regard to public health relevance, evidence on efficacy and safety, and comparative cost-effectiveness”.11 While most reasons to develop an essential medicine list focus on fairness of access to medicine, consensus on first choice treatment and reduction of health care cost, it also helps to concentrate medical procurement and SCM efforts on a limited number of items in terms of quality control and medicine management, ie. stock management, distribution and monitoring of medical supply pipelines (Table 3). Moreover, the WHO essential medicines criteria also focus on medicine quality in terms of potency, uniformity, stability and also bioavailability; common denominators of medicine quality to be taken into account with respect to quality assurance in medical humanitarian supply chains.

Table 3: WHO criteria for the selection of essential medicines11

10 11

MSH 2012, pp. 289. WHO 2008; 2010B, 2011D, 2011E and 2012.

Page 13 of 33

Humanitarian organizations implementing medical programs in a variety of response phases often follow the essential medicines list of the WHO, the recipient country’s MoH essential medicine list if more stringent, or internationally agreed catalogues of standardized medical items based upon the WHO essential medicine list. Operating in the emergency response phase, humanitarian organizations often make use of the IFRC or interagency emergency health kits, which have been prequalified and cover the minimum needs for basic health-care systems under emergency circumstances.12 WHO / UN / multilateral organizations’ essential medicine lists, related pre-qualified suppliers and interagency emergency health kits meet the medicine quality aspects as discussed and follow stringent quality assurance rules discussed in Chapter 3, making them the preferred procurement choice.

12

MSF 2010, IFRC 2011A and 2011B, UNICEF 2011, WHO 2011B, 2011D and 2011E.

Page 14 of 33

3. Critical elements of medical quality assurance
Quality assurance (QA) is a wide-ranging concept covering matters that individually or collectively influence the quality of a product. With regard to pharmaceuticals, quality assurance can be divided into four major areas: quality control, production, distribution, and inspections.

Figure 2: Elements of a quality assurance system13 While some humanitarian actors might have the capacity to implement all the elements of a quality assurance system, most humanitarian actors will depend on UN/multilateral bodies and their suppliers to be actively involved in specific quality assurance activities part of the QA system, ie. inspection of product samples, monitoring of manufacturing sites, product testing, certification, etc.

13

Adapted from MSH 2012, pp. 350.

Page 15 of 33

3.1 Quality assessment vs. quality assurance
Quality assessment is part of the (often mostly internal) quality management process and often refers to the (continuous) monitoring/measurement of quality within a humanitarian medical intervention, based on set policies, processes and protocols to assure a medical intervention is optimally delivered and it includes indicators that measure whether success is being achieved. Quality assurance is a wider process of guaranteeing quality, based on product (medicines, medical materials and equipment) and process quality indicators being measured and quality standards being reached through the quality management process. Common denominators of medicine quality have already been put forward; process quality standards focus on, among others, good manufacturing practices (GMP) – also captured in EC guidelines and standards, good distribution practices (GDP), good storage practices (GSP) and good trade and distribution practices (GTDP).14

Product and process quality management standards focus on the fundamentals of quality management systems that need to be in place to assure quality, as do the GMP and ISO standards.

3.2 Certification and quality assurance
Certification refers to the assurance of certain quality standards being in place. First-party certification refers to internal quality assessment and continuous monitoring, whereas second-party and third-party certification refers to qualification or certification by either an association to which the organization belongs or in the latter case certification by an independent, accredited body.

Suppliers and manufacturers can be qualified to work in line with (often voluntary) good practice process quality standards like the GMP, GDP, GSP or GTDP standards of the WHO and/or less voluntary EC equivalents, which are often part of a pre-qualification process of suppliers and manufacturers. At the same time they can be certified to follow specific quality management standards like ISO 9000:2005 and ISO 9001:2008, quality management standards specifically focusing on medical materials like the ISO 11608:2012 or ISO 10555:2013 series, standards for medical devices like ISO 13485: 2003 or the older equivalent EN 46001 / EN 46002, and standards focusing on packaging materials for medicinal products, like ISO 15378:2011.15

14 15

EC 1994 and 2003; WHO 2003A, 2003B and 2005; Pomatta and Schuftan 2006; WHO 2007; EC 2010; WHO 2010A, 2010C and 2010D; EC 2013. ISO 2005, 2007, 2008, 2011, 2012 and 2013.

Page 16 of 33

Procuring from suppliers/manufacturers registered and certified in countries that are considered to have “stringently regulated” national drug regulatory authorities16 guarantees the adherence to good practices and certified quality management standards, thus assuring the quality of medical items procured.

16

The following countries are considered to be highly regulated by their national drugs regulatory authorities: Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Malaysia, Netherlands, Norway, Portugal, Romania, Singapore, Slovak Republic, Spain, Sweden, Switzerland, UK, ICH European Union Members, Japan and USA.

Page 17 of 33

4. Quality assurance throughout the supply chain
Quality assurance throughout the supply chain is complex due to the fact that big parts of the supply chain, both downstream as well as upstream, will be external to the humanitarian organization implementing or taking part in a medical intervention. This complexity is further increased by the vast number of stakeholders17 involved in the external supply chain elements and related quality assurance. Despite these complexities, some recommendations towards quality assurance can be given for the supply chain management process in general and for each main supply chain component: - Different medical interventions and types of items used in them require that clear policies and procedures for procuring, moving, storing, using and disposing of items need to be in place. These need to be suitable for the particular programme, follow appropriate minimum standards and must be understood and followed by all actors involved in the supply chain process; - Roles and responsibilities of all supply chain actors should be very clear and defined both in general technical terms as well as towards quality assurance throughout the supply chain; - Quality assurance throughout the supply chain demands a clear information flow, containing all information necessary to handle and process medical orders and additional information on specific handling requirements, controlled substances, dangerous goods requirements, etc. by means of certificates, declarations, licenses and specific packaging, marking and labelling.

Procurement and order management: - Procurement, as the action of obtaining or acquiring supplies, can take place from suppliers, distributors, UN agencies, RCRC, donors or the government. Order management can be external from the humanitarian organization as implementing partner. Roles and responsibilities of all actors involved towards these processes as well as quality assurance should be clearly defined; - Procurement should be limited to pre-qualified suppliers (pre-qualified by e.g. WHO, UN, RCRC, MSF or a INGO collaborative like BOND or SHO) from “stringently regulated” countries and/or medical Humanitarian Procurement Centres (HPCs)18, following good practice process quality standards19 and with certified quality management standards;

17

First, second and third-tier ssuppliers, distributors, 3PL providers, governments, UN agencies, RCRC, standardization and/or quality control institutes, other humanitarian organizations, donors, etc. HPCs are not-for-profit organisations specialised in the technical and commercial management of supplies and services necessary for the implementation of humanitarian actions. They can provide technical assistance in procurement or supply pre-established stocks, purchasing or logistics capacity. http://ec.europa.eu/echo/partners/humanitarian_aid/procurement_en.htm [Accessed 28 June 2013]. WHO 1999 and 2007; MSF 2010; IFRC 2011A and 2011B; UNICEF 2011; WHO 2011D and 2011E; MSH 2012; WHO 2012.

18

19

Page 18 of 33

- The reverse goods flow – in case of quality problems, damage and/or expiration – should already be taken into account during the procurement phase; - All items should have not only technical specifications, but also quality indicators/specifications.

Transport: - Again a range of actors will be involved in the transport element, possibly cross-border and making use of a range of transport methods, and roles, responsibilities and specific quality and handling requirements in line with GDP / GTDP standards20 should be clear to all actors involved; - Transport must take place in line with international and national regulations, e.g. International Air Transport Association (IATA) regulations and regulations for controlled substances21; - Roles, responsibilities and quality assurance regarding the handling of goods during stevedoring and cross-docking activities should be clearly defined.

Warehousing and inventory: - Warehousing and inventories can take place at various stages in the supply chain, within or outside the scope of the humanitarian organization implementing or taking part in a medical intervention. Rules and regulations for the inspection, quality control and handling should be the same for all warehousing environments, irrespective of the actor managing it, in line with GSP standards22 and clear minimum standards should be put in place; - Clear quality management procedures should be put in place with specific damage reporting and quality problem reporting formats.

20 21 22

EC 1994; PAHO 2001; WHO 2003A; WHO 2005; Pomatto and Schuftan 2006; WHO 2007 and 2010A; USAID 2011; MSH 2012; EC 2013. UN 1971, 1988 and 2001; INCB 2008;IATA 2013. PAHO 2001; WHO 2003B; Pomatto and Schuftan 2006; WHO 1020C; USAID 2011; MSH 2012.

Page 19 of 33

5. Humanitarian response phases and quality assurance
Going back to Figure 1 in the introduction, on the humanitarian response phases, corresponding medical procurement and supply chain management actions per phase are visualized in Figure 3 and further explained below.

Figure 3: Humanitarian response phases and medical procurement actions Developmental programmes: With a certain demand and low responsiveness need, the focus is on essential medicines; open tendering for both medical procurement and order transport – from suppliers in stringently regulated countries or medical HPCs. International transport will be mainly by sea, if applicable. Disaster risk reduction / preparedness: The focus is on capacity development, supporting the government in adjusting the essential medicines list and streamlining its medical logistics and preparedness, focus on open tenders and development of blanket purchasing agreements, prepositioning of emergency medical stocks and transport will be mainly by sea, if applicable. Emergency response: Focus on the use of emergency health kits, possibly as implementing partner in a coordinated response, most items come from pre-positioned stocks and the focus is on high responsiveness and as such air transport is the main mode of transport. Transitional programmes: Move from the ordering / use of emergency health kits to essential medicines from suppliers in stringently regulated countries and/or medical HPCs, calling from partly pre-positioned goods under blanket purchasing agreements. Transport will be a combination of air and sea transport, as far as applicable.

Page 20 of 33

6. Concluding
Quality assurance in humanitarian medical supply chains demands a coordinated multi-stakeholder approach, currently already reflected in the inclusive way in which good practice standards are developed, adapted and implemented by the WHO, UN, RCRC, EC, INGO stakeholders, governmental and commercial partners. Although ownership, alignment, harmonization, results-oriented management and mutual accountability are the five pillars of the Paris Declaration of Aid Effectiveness23, which inspired the International Health Partnership (IHP+) focusing on the health-related Millennium Development Goals (MDGs), this has not yet resulted in a concerted humanitarian supply chain wide approach to quality assurance and related management of humanitarian medical supply chains.

One solution might be the integration of current medical Humanitarian Procurement Centres (HPCs)24 in the IHP+ to guarantee their adherence to all medical good practice standards, a higher level of coordination between HPCs and provision of services by all stakeholders under IHP+ that go beyond their internal medical supply chain and current level of service, ie. supply of trainers, quality assessors, emergency pharmacists, etc. Another solution might be to only accept humanitarian actors in humanitarian medical interventions – or in any type of humanitarian intervention as such – who can prove a minimum level of quality assurance in their work processes and outputs. This would also make sense to curtail the uncontrollable flood of humanitarian initiatives after a disaster.

23 24

OECD 2008. http://ec.europa.eu/echo/files/partners/humanitarian_aid/HPC-register_en.pdf [Accessed 30 June 2013].

Page 21 of 33

[This page has been left blank intentionally for double-sided printing]

Page 22 of 33

References
BUCHANAN-SMITH, M. and RANDEL, J., 2002. Financing international humanitarian action: a review of key trends. Humanitarian Policy Group Briefing Papers. [online]. 4, pp. 1-4. Available from: http://www.odi.org.uk/sites/odi.org.uk/files/odi-assets/publications-opinion-files/365.pdf [Accessed 14 April 2013]. CHOPRA, S. and MEINDL, P., 2013. Supply chain management: Strategy, planning and operation. 5th ed. Harlow, Essex: Pearson Education Limited. COHEN, S. and ROUSSEL, J., 2005. Strategic supply chain management: The five disciplines for top performance. New York, NY: McGraw-Hill. DASAKLIS, T. K., PAPPIS, C. P. and RACHANIOTIS, N. P., 2012. Epidemics control and logistics operations: A review. International Journal of Production Economics, 139, pp. 393–410. EC, 1994. Guidelines on good distribution practice of medicinal products for human use (94/C 63/03). [online]. Brussels: The European Commission (EC). Available from: http://ec.europa.eu/ health/files/eudralex/vol-4/gdpguidelines1.pdf [Accessed 21 June 2013]. EC, 2003. Commission directive 2003/94/EC of 8 October 2003 laying down the principles and guidelines of good manufacturing practice in respect of medicinal products for human use and investigational medicinal products for human use. [online]. Brussels: The European Commission (EC). Available from: http://ec.europa.eu/health/files/eudralex/vol-1/dir_2003_94/dir_2003_94_en.pdf [Accessed 21 June 2013]. EC, 2010. EU guidelines to good manufacturing practice of medicinal products for human and veterinary use - Part II: Basic requirements for active substances used as starting materials. [online]. Brussels: The European Commission (EC). Available from: http://ec.europa.eu/health

/files/eudralex/vol-4/2007_09_gmp_part2_en.pdf [Accessed 21 June 2013]. EC, 2013. Guidelines on good distribution practice of medicinal products for human use (2013/C 68/01) – revised rules entering into force on 8 March 2014. [online]. Brussels: The European Commission (EC). Available from: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?

uri=OJ:C:2013:068:0001:0014:EN:PDF [Accessed 21 June 2013]. EMEA, 2000. Note for guidance on the investigation of bioavailability and bioequivalence. [online]. London: The European Medicines Agency (EMEA), Committee for Medicinal Products for Human Use. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/

2009/09/WC500003519.pdf [Accessed 16 May 2013].

Page 23 of 33

EMEA, 2010. Guideline on the investigation of bioequivalence. [online]. London: The European Medicines Agency (EMEA), Committee for Medicinal Products for Human Use. Available from: http://www.emea.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/01/WC5000 70039.pdf [Accessed 16 May 2013]. GUSTVASSON, L., 2003. Humanitarian logistics: context and challenges. Forced Migration Review. [online]. 18, pp. 6-8. Available from: http://www.fmreview.org/FMRpdfs/FMR18/fmr18full.pdf [Accessed 22 April 2013]. IATA, 2013. Dangerous Goods Regulations (DGR). 54th edition. Montreal: International Air Transport Association (IATA). IFRC, 2002. Handbook for delegates. [online]. Geneva: International Federation of Red Cross and Red Crescent Societies. Available from: http://www.ifrc.org/PageFiles/95733/07.%20Handbook

%20for%20delegates_IFRC.pdf [Accessed 4 May 2013]. IFRC, 2011A. IFRC Catalogue Volume 2: Medical supplies. [online]. Geneva: the International Federation of the Red Cross (IFRC). Available from: http://procurement.ifrc.org/catalogue /overview.aspx?volume=2 [Accessed 22 June 2013]. IFRC, 2011B. IFRC Catalogue Volume 3: Emergency health kits. [online]. Geneva: the International Federation of the Red Cross (IFRC). Available from: http://procurement.ifrc.org/catalogue /overview.aspx?volume=3 [Accessed 22 June 2013]. INCB, 2003. List of psychotropic substances under international control. [online]. Vienna: International Narcotics Control Board (INCB). Available from: http://www.incb.org/pdf/

e/list/green.pdf [Accessed 26 June 2013]. ISO, 2005. ISO 9000:2005. Quality management systems - Fundamentals and vocabulary. Geneva: International Organization for Standardization, ISO Central Secretariat. ISO 2007. ISO 13485:2003 Medical devices - Quality management systems - Requirements for regulatory purposes. Geneva: International Organization for Standardization, ISO Central Secretariat. ISO, 2008. ISO 9001:2008. Quality management systems – Requirements. Geneva: International Organization for Standardization, ISO Central Secretariat. ISO, 2011. ISO 15378:2011. Primary packaging materials for medicinal products - Particular requirements for the application of ISO 9001:2008, with reference to Good Manufacturing Practice (GMP). 2nd edition. Geneva: International Organization for Standardization, ISO Central Secretariat. ISO, 2012. ISO 11608:2012. Needle-based injection systems for medical use - Requirements and test methods. 2nd edition. Geneva: International Organization for Standardization, ISO Central Secretariat.
Page 24 of 33

ISO, 2013. ISO 10555:2013. Intravascular catheters - Sterile and single-use catheters. 2nd edition. Geneva: International Organization for Standardization, ISO Central Secretariat. LEE, H.L., and LEE, C.Y., eds., 2007. Building supply chain excellence in emerging economies, ISBN 9780387384283, New York, NY: Springer. MOSADEGHRAD, A. M., 2013. Obstacles to TQM success in health care systems. International Journal of Health Care Quality Assurance, 26(3), pp. 147-173. MSF, 2010. Essential drugs - Practical guidelines intended for physicians, pharmacists, nurses and medical auxiliaries. [online]. Amsterdam: Médècins Sans Frontières, Operational Centre Amsterdam. Available from: http://apps.who.int/medicinedocs/documents/s17080e/s17080e.pdf [Accessed 19 June 2013]. MSH, 2007. Drug and therapeutics committee training course. [online]. Submitted to the United States Agency for International Development (USAID) by the Rational Pharmaceutical Management Plus Program. Arlington, VA: Management Sciences for Health (MSH). Available from: http://www.who.int/medicines/technical_briefing/tbs/Participant-s-Guide-All-Sessions.pdf [Accessed 12 May 2013] MSH, 2012. MDS-3: Managing access to medicines and health technologies.3rd ed. [online]. Arlington, VA: Management Sciences for Health. Available from: http://www.msh.org/resource-center/ publications/upload/MDS3-November2012.pdf [Accessed 11 May 2013]. OECD, 2008. The Paris Declaration on Aid Effectiveness (2005) and the Accra Agenda for Action (2008). [online]. Paris: Organisation for Economic Co-operation and Development (OECD). Available from: http://www.oecd.org/development/effectiveness/34428351.pdf [Accessed 30 June 2013]. OWENS, R.C., Jr. and WARNER, T., 2003. Concepts of logistics system design. [online]. Arlington, VA: John Snow Inc. / DELIVER Project for the US Agency for International Development (USAID). Available from: http://deliver.jsi.com/dlvr_content/resources/allpubs/guidelines/ConcLogiSystDesi.pdf

[Accessed 13 April 2013]. PAHO, 2001. Humanitarian Supply Management and Logistics in the Health Sector. [online]. Washington DC: Pan-American Health Organization, Emergency Preparedness and Disaster Relief Programme. Available from: http://www.who.int/hac/techguidance/tools/LSS.pdf [Accessed 16 April 2013]. PATH, 2011. Developing a vision for immunization supply systems in 2020: Landscape analysis summaries. [online]. Seattle, WA: PATH. Available from: http://www.path.org/publications/ files/TS_opt_vision_2020.pdf [Accessed 16 May 2013].

Page 25 of 33

POMATTO, V. and SCHUFTAN, C., 2006. Review of quality assurance (QA) mechanisms for medicines and medical supplies in humanitarian aid – guidelines. [online]. Brussels, Belgium: DG ECHO. Available from: http://ec.europa.eu /echo/files/evaluation/drugs_quality_guidelines.pdf [Accessed 3 May 2013]. SPHERE, 2011. The sphere project – Humanitarian charter and minimum standards in humanitarian response. The Sphere Project. [online]. Bourtn on Dunsmore, UK: Practical Action Publishing, Schumacher Centre for Technology and Development. Available from: www.spherehandbook.org [Accessed 10 May 2013]. SUNIL, C., and MEINDL, P., 2009. Supply chain management. 4th ed. Upper Saddle River, NJ: Prentice Hall. TOUTAIN, P. L. and BOUSQUET-MELOU, A., 2004. Bioavailability and its assessment. Journal of Veterinary Pharmacology and Therapeutics, 27, pp. 455–466. UN, 1971. Convention on Psychotropic Substances. [online]. New York, NY: United Nations Economic and Social Council, Available from: http://www.unodc.org/unodc/en/Resolutions/resolution_197105-20_1.html [Accessed 26 June 2013]. UN, 1988. United Nations convention against the illicit traffic in narcotic drugs and psychotropic substances. [online]. New York, NY: United Nations. Available from: http://www.unodc.org/pdf/ convention_1988_en.pdf [Accessed 26 June 2013]. UN, 2001. Recommendations on the transport of dangerous goods. [online]. New York, NY: United Nations (UN). Available from: http://www.unece.org/fileadmin/DAM/trans/danger/publi/unrec/ English/Recommend.pdf [Accessed 26 June 2013]. UNICEF, 2011. UNICEF Medical kits. [online]. Copenhagen: UNICEF Supply Center Copenhagen. Available from: https://supply.unicef.org/ [Accessed 23 June 2013]. USAID, 2011. Deliver project Task Order 1: The logistics handbook – a practical guide for the supply chain management of health commodities. 2nd ed. [online]. Arlington, VA: United States Agency for International Development (USAID). Available from: http://deliver.jsi.com/dlvr_content/

resources/allpubs/guidelines/LogiHand.pdf [Accessed 3 May 2013]. VAN WASSENHOVE, L.N., 2006. Blackett memorial lecture humanitarian aid logistics: supply chain management at high gear. Journal of the Operational Research Society. [online]. 57(5), pp. 475-489. Available from: http://www.palgrave-journals.com/jors/journal/v57/n5/pdf/2602125a.pdf [Accessed 8 April 2013].

Page 26 of 33

WHO, 1997. Quality assurance of pharmaceuticals: A compendium of guidelines and related materials - Volume 1. [online]. Geneva: World Health Organization (WHO). Available from: http://apps.who.int/medicinedocs/pdf/h1813e/h1813e.pdf [Accessed 17 May 2013]. WHO, 1999. Operational principles for good pharmaceutical procurement. [online]. Geneva: World Health Organization (WHO). Available from: http://www.who.int/3by5/en/who-edm-par-99-5.pdf [Accessed 17 May 2013]. WHO, 2003A. Annex 2: WHO good trade and distribution practices for pharmaceutical starting materials. [online]. Geneva: World Health Organization (WHO). Available from:

http://apps.who.int/medicinedocs/documents/s19951en/s19951en.pdf [Accessed 21 June 2013]. WHO, 2003B. Annex 9: WHO guide to good storage practice for pharmaceuticals. [online]. Geneva: World Health Organization (WHO). Available from: http://apps.who.int/medicinedocs/documents /s18675en/s18675en.pdf [Accessed 21 June 2013]. WHO, 2005. Good distribution practice for pharmaceutical products. [online]. Geneva: World Health Organization (WHO). Available from: http://www.who.int/medicines/services/expertcommittees /pharmprep/QAS_068Rev2_GDPdraft.pdf [Accessed 21 June 2013]. WHO, 2007. Quality assurance of pharmaceuticals: Volume 2, second updated edition – Good manufacturing practices and inspection. [online]. Geneva: World Health Organization (WHO). Available from: http://www.who.int/medicines/areas/quality_safety/quality_assurance/Quality

AssurancePharmVol2.pdf [Accessed 3 May 2013]. WHO, 2009. WHO Model formulary 2008. [online]. Geneva: World Health Organization (WHO). Available from: http://apps.who.int/medicinedocs/documents/s16879e/s16879e.pdf [Accessed June 8 2013]. WHO, 2010A. Annex 5: WHO good distribution practices for pharmaceutical products. [online]. Geneva: World Health Organization (WHO). Available from: http://www.who.int/medicines/areas /quality_safety/quality_assurance/GoodDistributionPracticesTRS957Annex5.pdf [Accessed 21 June 2013]. WHO, 2010B. How to develop a national essential medicines list – Consultation draft for the 18th Expert Committee on the selection and use of essential medicines. [online]. Geneva: World Health Organization (WHO). Available from: http://www.who.int/selection_medicines/

committees/expert/18/How_to_developNEML_agenda_paper.pdf [Accessed 7 June 2013]. WHO, 2010C. Model requirements for the storage and transport of time and temperature sensitive pharmaceutical products, working draft V2b. [online]. Geneva: World Health Organization (WHO).

Page 27 of 33

Available

from:

http://www.who.int/immunization_standards/model_requirements_v2b.pdf

[Accessed 2 May 2013]. WHO, 2011A. Quality assurance of pharmaceuticals: Meeting a major public health challenge. [online]. Geneva: World Health Organization (WHO). Available from: http://www.who.int/ medicines/publications/BrochurePharmaupdatedversion.pdf [Accessed 10 May 2013]. WHO, 2011B. The interagency emergency health kit 2011 - Medicines and medical devices for 10,000 people for approximately three months. [online]. Geneva: World Health Organization (WHO). Available from: http://whqlibdoc.who.int/publications/2011/9789241502115_eng.pdf [Accessed 23 June 2013]. WHO, 2011C. WHO expert committee on specifications for pharmaceutical preparations: Outcome of 44 meetings. [online]. Geneva: World Health Organization (WHO). Available from:

http://www.who.int/medicines/services/expertcommittees/pharmprep/PharmPrep44meetrepport.p df [Accessed 10 May 2013]. WHO, 2011D. WHO model list of essential medicines, 17th List – March 2011. [online]. Geneva: World Health Organization (WHO). Available from: http://whqlibdoc.who.int/hq/2011/ a95053_eng.pdf [Accessed 22 June 2013]. WHO, 2011E. WHO model list of essential medicines for children, 3rd List – March 2011. [online]. Geneva: World Health Organization (WHO). Available from: http://whqlibdoc.who.int/

hq/2011/a95054_eng.pdf [Accessed 22 June 2013]. WHO, 2012. The selection and use of essential medicines: Report of the WHO Expert Committee – March 2011. [online]. Geneva: World Health Organization (WHO). Available from:

http://whqlibdoc.who.int/trs/WHO_TRS_965_eng.pdf [Accessed 4 June 2013].

Page 28 of 33

Recommended reading
AKKIHAL, A., 2006. Inventory pre-positioning for humanitarian logistics. Thesis. [online]. MIT Center for Transport and Logistics, Massachusetts Institute of Technology. Available from:

http://dspace.mit.edu/handle/1721.1/36318 [Accessed 18 March 2013]. APPELBAUM, S.H., NADEAU, D. and CYR, M., 2008A. Performance evaluation in a matrix organization: a case study (Part one). Industrial and Commercial Training, 40(5), pp. 236-241. APPELBAUM, S.H., NADEAU, D. and CYR, M., 2008B. Performance evaluation in a matrix organization: a case study (Part two). Industrial and Commercial Training, 40(6), pp. 295-299. APPELBAUM, S.H., NADEAU, D. and CYR, M., 2009. Performance evaluation in a matrix organization: a case study (Part three). Industrial and Commercial Training, 41(1), pp. 9-14. ARGOLLO DA COSTA, S.R., CAMPOS, V.B.G. and ALBERGARIA DE MELLO BANDEIRA, R., 2012. Supply chains in humanitarian operations: Cases and analysis. Social and Behavioral Sciences, 54, pp. 598 – 607. ARONSSON, H., ABRAHAMSSON, M. and SPENS, K., 2011. Developing lean and agile health care supply chains. Supply Chain Management: An International Journal, 16(3), pp. 176-183. AZAM, M. et. al., 2012. A critical study of quality parameters in health care establishment. Developing an integrated quality model. International Journal of Health Care Quality Assurance, 25(5), pp. 387-402. BALCIK, B., et. al., 2010. Coordination in humanitarian relief chains: Practices, challenges and opportunities. International Journal of Production Economics, 126, pp. 22–34. BEAMON, B.M., 2004. Humanitarian relief chains: Issues and challenges. Proceedings of the 34th International Conference on Computers & Industrial Engineering, November 14-16 2004. San Francisco, CA. pp. 77 – 82. BESIOU, M., PEDRAZA-MARTINEZ, A.J. and VAN WASSENHOVE, L., 2012. The effect of earmarked funding on fleet management for relief and development. Working paper. [online]. Singapore: INSEAD. Available from: http://www.insead.edu/facultyresearch/research/doc.cfm?did=49163

[Accessed 3 April 2013] BLANCO, E.E. and GOENTZEL, J., 2006. Supply Chain Management. [lecture notes]. Humanitarian supply chains: a review. Massachusetts Institute of Technology (MIT), Center for Transportation and Logistics, April 2006. BURGESS, N. and RADNOR, Z., 2013. Evaluating Lean in healthcare. International Journal of Health Care Quality Assurance, 26(3), pp. 220-235.
Page 29 of 33

CASSIDY, W.B., 2003. A logistics lifeline. Traffic World, 27, pp. 1. CASSIDY, W.B., 2010. The humanitarian logistics gap. The Journal of Commerce, East Windsor, NJ: UBM Global Trade. DURAN, S., GUTIERREZ, M.A. and KESKINOCAK, P., 2011. Pre-positioning of emergency items for CARE International. Interfaces, 41(3), pp. 223-237. EAKIN, L., 2002. Supporting organizational infrastructure in the voluntary sector. [online]. Background paper prepared for the Voluntary Sector Initiative. Ottawa, Canada: VSI Secretariat. Available from: http://www.vsi-isbc.org/eng/funding/pdf/supporting_organizational_

infrastructure.pdf [Accessed March 24 2013]. ERGUN, O., et. al., 2009. Humanitarian supply chain management – An overview. Seminar 09261 Models and Algorithms for Optimization in Logistics. [online]. October 2 2009. H. Milton Stewart School of Industrial and Systems Engineering, Georgia Institute of Technology, Atlanta, GA. pp. 1 – 7. Available from: http://drops.dagstuhl.de/volltexte/2009/2181/pdf/09261.ErgunOzlem.

ExtAbstract.2181.pdf [Accessed 15 March 2013]. GOLDRATT, E.M., 2004. The Goal - A Process of Ongoing Improvement. 3rd ed. Great Barrington, MA: North River Press. GRAVES, S. and WHEELER, V., 2006. Good humanitarian donorship: Overcoming obstacles to improved collective donor performance – Discussion paper 261. [online]. London, UK: ODI Humanitarian Practice Network. Available from: http://www.odi.org.uk/publications/261-goodhumanitarian-donorship-collective-donor-performance [Accessed 26 March 2013]. HEASLIP, G., SHARIF, A.M. and ALTHONAYAN, A., 2012. Employing a systems-based perspective to the identification of inter-relationships within humanitarian logistics. International Journal of Production Economics, 139, pp. 377–392. HOLGUÍN-VERAS, J., et. al., 2012. On the unique features of post-disaster humanitarian logistics. Journal of Operations Management, 30, pp. 494–506. ICRC, 2008. Guidelines for assessment in emergencies. [online]. Geneva: International Committee of the Red Cross and Red Crescent Societies. Available from: http://www.ifrc.org/Global/Publications /disasters/guidelines/guidelines-emergency.pdf [Accessed 12 April 2013]. JAHRE, M., et. al., 2010. Improving health systems in developing countries by reducing the complexity of drug supply chains. RIRL 2010: The 8th International Conference on Logistics and SCM Research. September 29 - October 1 2010. Bordeaux: BEM Bordeaux Management School, pp. 1-23.

Page 30 of 33

KAATRUD, D.B., SAMII, R. and WASSENHOVE, L.N. van, 2003. UN Joint Logistics Centre: A coordinated response to common humanitarian logistics concerns. Forced Migration Review. [onlne]. 18, pp. 1114. Available from: http://www.fmreview.org/FMRpdfs/FMR18/fmr18full.pdf [Accessed 2 April 2013]. KLARE, M.T., 2009. Resource competition in the 21st century. In: A. RICCI, ed. European Commission Instrument for Stability, From early warning to early action? [online]. Brussels: European Union, pp. 293-301. Available from: http://eeas.europa.eu/ifs/publications/articles/book2/book%20vol2_

part3_chapter38_resource%20competition%20in%20the%2021st%20century_michael%20t.%20klare .pdf [Accessed 17 April 2013]. KOVÁCS, G. and SPENS, K.M., 2007. Humanitarian logistics in disaster relief operations. International Journal of Physical Distribution & Logistics Management, 37(2), pp. 99-114. KOVÁCS, G. and SPENS, K.M., 2009. Identifying challenges in humanitarian logistics. International Journal of Physical Distribution & Logistics Management, 39(6), pp. 506-528. KUMAR, S., NIEDAN-OLSEN, K. and PETERSON, L., 2009. Educating the supply chain logistics for humanitarian efforts in Africa: a case study. International Journal of Productivity and Performance Management, 58(5), pp. 480-500. KUMAR, A., OZDAMAR, L. and NG, C. P., 2005. Procurement performance measurement system in the health care industry. International Journal of Health Care Quality Assurance, 18(2), pp. 152-166. KUMAR, S., SWANSON, E. and TRAN, T., 2009. RFID in the healthcare supply chain: usage and application. International Journal of Health Care Quality Assurance, 22(1), pp. 67-81. LYSONS, K. and FARRINGTON, B., 2006. Purchasing and supply chain management. 7th ed. Harlow, Essex: Pearson Education Limited. PAZIRANDEH, A., 2011. Sourcing in global health supply chains for developing countries: Literature review and a decision making framework. International Journal of Physical Distribution & Logistics Management, 41(4), pp. 364-384. PEDRAZA-MARTINEZ, A.J., STAPLETON, O. and VAN WASSENHOVE, L., 2011. Field vehicle fleet management in humanitarian operations: A case-based approach. Journal of Operations Management, 29(5), pp. 404-421. RAHIMNIA, F. and MOGHADASIAN, M., 2010. Supply chain leagility in professional services: How to apply decoupling point concept in healthcare delivery system. Supply Chain Management: An International Journal, 15(1), pp. 80-91.

Page 31 of 33

RIVARD-ROYER, H., LANDRY, S. and BEAULIEU, M., 2002. Hybrid stockless: A case study - Lessons for health-care supply chain integration. International Journal of Operations & Production Management, 22(4), pp. 412-424. ROBERTSON, D. W., et. al., 2002. What kind of evidence do we need to justify humanitarian medical aid? The Lancet, 360, pp. 330-333. RUSSELL, 2005. The humanitarian relief supply chain: Analysis of the 2004 South East Asia

earthquake and tsunami. Thesis. [Online]. MIT Center for Transport and Logistics, Massachusetts Institute of Technology. Available from: http://dspace.mit.edu/handle/1721.1/33352 [Accessed 12 March 2013]. SAMUEL, C., et. al., 2010. Supply chain dynamics in healthcare services. International Journal of Health Care Quality Assurance, 23(7), pp. 631-642. SCHRAGENHEIM, E., DETTMER, H.W. and PATTERSON, J.W., 2009. Supply chain management at warp speed: Integrating the system from end to end. New York: Auerbach Publications. SIMATUPANG, T.M., WRIGHT, A.C. and SRIDHARAN, R. , 2004. Applying the theory of constraints to supply chain collaboration. Supply Chain Management: An International Journal, 9(1), pp. 1-29. SONDORP, E., KAISER, T. and ZWI, A., 2001. Editorial: Beyond emergency care: challenges to health planning in complex emergencies. Tropical Medicine and International Health, 6(12), pp. 965-970. SRINIVASAN, M., 2011. Building lean supply chains with the theory of constraints. 1st ed. New York: McGraw-Hill Professional. SUAREZ, P. and TALL, A., 2010A. Towards forecast-based humanitarian decisions: Innovation to foster dialogue between disaster managers and scientists. [online]. The Hague: Red Cross and Red Crescent Climate Centre. Available from: http://www.climatecentre.org/downloads/File/programs/2-

pager%20EWEA%20RC%20workshop%20dynamics.pdf [Accessed 8 April 2013]. SUAREZ, P., and TALL, A., 2010B. Towards forecast-based humanitarian decisions: Climate science to get from early warning to early action. [online]. London: Kings College, Humanitarian Futures Programme. Available from: http://www.humanitarianfutures.org/sites/default/files/

Towards%20forecast-based%20humanitarian%20decisions%20-%20Discussion%20Paper.pdf [Accessed 8 April 2013]. SWINEHART, K. D. and SMITH, A. E., Internal supply chain performance measurement: A health care continuous improvement implementation. International Journal of Health Care Quality Assurance, 18(7), pp. 533-542.

Page 32 of 33

TATHAM, P. and KOVÁCS, G., 2010. The application of ‘‘swift trust’’ to humanitarian logistics. International Journal of Production Economics, 126, pp. 35–45. THOMAS, A., 2003. Humanitarian logistics: Enabling disaster response. [online]. San Francisco, CA: The Fritz Institute. Available from: http://www.fritzinstitute.org/pdfs/whitepaper/

enablingdisasterresponse.pdf [Accessed 4 March 2013]. UMBLE, M. UMBLE, E. and VON DEYLEN, 2001. Integrating enterprise resources planning and theory of constraints: a case study. Production and Inventory Management Journal, 42(2), pp. 43-48. UNOCHA, 2010. Humanitarian Appeal 2010 – Consolidated Appeal Process (CAP). [online]. New York, NY: United Nations Office for the Coordination of Humanitarian Affairs (UNOCHA). Available from: http://ochadms.unog.ch/quickplace/cap/main.nsf/h_Index/CAP_2010_Humanitarian_Appeal/$FILE/ CAP_2010_Humanitarian_Appeal_SCREEN.pdf [Accessed 15 March 2013]. USAID, 2009. Planning and implementing a logistics system design activity. [online]. Arlington, VA: DELIVER Project for the US Agency for International Development (USAID). Available from: http://deliver.jsi.com/dlvr_content/resources/allpubs/guidelines/PlannImplLogiSyst.pdf [Accessed 2 March 2013] VALENTINO, B.A., 2011. The true cost of humanitarian intervention. Foreign Affairs, 90(6), pp. 60-73. VAN DEN HEUVEL, J., NIEMEIJER, G. C. and DOES, R. J. M. M., 2013. Measuring healthcare quality: the challenges. International Journal of Health Care Quality Assurance, 26(3), pp. 269-278. VAN VACTOR, J. D., 2013. Leveraging the Patient-Centered Medical Home (PCMH) model as a health care logistics support strategy. Leadership in Health Services, 26(2), pp. 95-106. VAN WEELE, A.J., 2010. Purchasing and supply chain management: Analysis, strategy, planning and practice. 5th ed. Andover, Hampshire: Cengage Learning EMEA. WALTERS, D. and JONES, P., 2001. Value and value chains in healthcare: a quality management perspective. The TQM Magazine, 13(5), pp. 319-333.

Page 33 of 33

Sponsor Documents

Or use your account on DocShare.tips

Hide

Forgot your password?

Or register your new account on DocShare.tips

Hide

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close